Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-27

Clinical Trial Update: A Natural History Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5)

View source ↗

Summary

This update reports the completion of a natural history (observational) study of Ceroid Lipofuscinosis, Neuronal 5 (CLN5).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Neurogene Inc. | Conditions: Ceroid Lipofuscinosis, Neuronal 5 | Status: COMPLETED